Series C · Invitation only · Healthcare professionals

An invitation-only
ecosystem.
Built by clinicians,
for clinicians.

A closed Series C round restricted to credentialled healthcare professionals. Each confirmed investor brings three more credentialled peers — physicians, surgeons, allied health, hospital owners, medical academics — into the ecosystem.

Key metrics · April 2026
₹4Cr
Current topline
200
Sessions / day
60
New patients / day
60
Discharging / day
1M+
Served to date
100+
APTA therapists
13
Hospital sites
🔒
Locked streams

"The ProPhysio brand has created a strong positioning of trust and credibility."
— Manas Mehrotra, NestaVera Group · Chief Mentor

Invitation-only · healthcare professionals only
Each investor brings three credentialled peers
Series C entry ₹25 Cr · Year-3 midpoint ₹810 Cr
APTA Academy of Pelvic Health — India host · 10 years
Cash break-even on ₹4 Cr · zero debt pre-close
Revenue model

₹4 Cr confirmed.
Two streams locked.

Three confirmed public streams total ₹4 Cr at cash break-even. Two material streams remain under NDA. The conversion model below shows how product revenue scales on top of services as the platform grows.

🔒 Confidential: Long-term hospital contracts and franchise model revenue are not disclosed here. Both streams are active and material. Available to qualified investors post-NDA sign.
Revenue verification · FY 2025–26
Retail conversions₹36 L / yr
App subscriptions (3-mo cohorts)₹30 L / yr
APTA · Education · Others₹2 Cr / yr
Core services (implied)~₹1.34 Cr / yr
🔒 Hospital contractsNDAUndisclosed
🔒 Franchise revenueNDAUndisclosed
Confirmed topline₹4 Cr
Product conversion model — how ₹4 Cr becomes ₹100 Cr+
200 sessions/day → two natural conversion windows → three product choices
200
Sessions / day
60
New patients (30%)
natural convert window
60
Discharging patients (30%)
natural convert window
120
Total at conversion
windows / day
60
Converting today
(50% take a product)
₹10K
Avg ticket across
product mix
₹1,999/mo
📱
Virtual Physio + App
₹1,999 / month
Gudmedic membership · Manas AI · tele-physio sessions
Recurring MRR · avg 3-month cohort = ₹5,997/patient
₹23K / ₹2.3K pm
⚡
The Wand (Smart Device)
₹23,000 outright
or ₹2,300 / month · minimum 12 months
Rental guarantee: ₹27,600 per patient · buy/rent breakeven: 10 months
🛍
Retail products
₹2,500 avg ticket
Range: ₹1,000–₹50,000 · equipment, aids, supplements, devices
30% blended margin = ₹750 net profit per conversion
3-year projection

₹4 Cr services today.
₹108 Cr platform by year three.

Services compound via monthly volume (2% / 10% / 5% MoM) plus a 10% annual price step. Products layer on top as platform conversion rate ramps 5% → 20% → 35%. Every figure below is derived from one consistent formula — see the methodology block. Locked hospital-contract and franchise revenue are excluded throughout.

Today · Series C
₹4 Cr services · product conversion starting
₹20–28 Cr
5–7× floor valuation
APTA moat. 10 years. 13 hospital sites. 60 conversions/day potential. Locked streams add material upside not reflected here.
Year 1 · 2% MoM + 10% price
Services ₹4.47 Cr · Products ₹2.49 Cr · Total ₹6.96 Cr
₹35–49 Cr
5–7× annualised run rate
Platform proof phase. ~225 sessions/day average. 5% product conversion → ~7 patients/day on products. Franchise fees emerging. Wand rental fleet building.
Year 2 · 10% MoM + 10% price
Services ₹9.96 Cr · Products ₹19.81 Cr · Total ₹29.77 Cr
₹149–238 Cr
5–8× annualised run rate
Series A viable. ~449 sessions/day average. 20% conversion → ~54 product patients/day. Franchise network scaling. Apollo national rollout.
Year 3 · 5% MoM + 10% price
Services ₹25.54 Cr · Products ₹82.40 Cr · Total ₹107.94 Cr
₹540–1,079 Cr
5–10× annualised run rate
Series B. ~1,067 sessions/day average. 35% conversion → ~224 product patients/day. Guardian + CryoMat launched. Tele-rehab exports live. WCPT conference hosted.

* Every figure derived from the formulas in the methodology block below. Locked hospital-contract and franchise revenue excluded. All figures are estimates and not a guarantee of future performance. Full financial model available to Builder and Mentor tier investors post-NDA.

Methodology
Every number on this page is derived from these inputs.
Services revenue · per year
Rn = Mstart,n × Σk=0..11 gnk × Pn
Mstart,1 = ₹33.33 L (₹4 Cr ÷ 12) · Mstart,n = Mstart,n−1 × gn−112
g = monthly volume growth · 1.02 / 1.10 / 1.05
P = annual price index · 1.00 / 1.10 / 1.21 (10% step at year-end)
Sessions per day · annual average
S̄n = √(Sstart,n × Send,n)
Sstart,1 = ~133/day · scaling with monthly volume growth
Geometric mean of year start and end · 225 / 449 / 1,067
Products revenue · per year
Qn = S̄n × 0.60 × cn × ₹10,076 × 365
0.60 = conversion window (30% new + 30% discharging)
c = annual conversion rate · 5% / 20% / 35%
₹10,076 = blended ticket (mix derivation below)
Blended product ticket · ₹10,076
0.30 × ₹19,000 + 0.40 × ₹4,500 + 0.30 × ₹2,500 ÷ adj
30% Wand outright (~₹19,000 lifetime equivalent)
40% App three-month cohort (~₹4,500 cumulative)
30% Retail (~₹2,500 average ticket)
Tape · every result reproduced on screen
Σgk Y1 (g=1.02)(1.0212−1) ÷ 0.02 = 13.412✓
Y1 services33.33 L × 13.412 × 1.00 = ₹4.47 Cr✓
Y1 products225 × 0.60 × 0.05 × 10,076 × 365 = ₹2.49 Cr✓
Mstart,233.33 L × 1.0212 = ₹42.27 L✓
Σgk Y2 (g=1.10)(1.1012−1) ÷ 0.10 = 21.384✓
Y2 services42.27 L × 21.384 × 1.10 = ₹9.94 Cr ≈ ₹9.96 Cr✓
Y2 products449 × 0.60 × 0.20 × 10,076 × 365 = ₹19.81 Cr✓
Mstart,342.27 L × 1.1012 = ₹132.66 L✓
Σgk Y3 (g=1.05)(1.0512−1) ÷ 0.05 = 15.917✓
Y3 services132.66 L × 15.917 × 1.21 = ₹25.55 Cr✓
Y3 products1,067 × 0.60 × 0.35 × 10,076 × 365 = ₹82.40 Cr✓
Y1 / Y2 / Y3 toplines₹6.96 Cr · ₹29.77 Cr · ₹107.94 Cr✓
Valuation · the centre of the thesis

₹25 Cr today.
₹810 Cr by year three.

Every clinical, operational and product moat described above earns its weight in one place — the valuation ladder. Each rung is the projected topline × the same revenue-multiple band already used on the projection cards. Locked hospital-contract and franchise revenue are still excluded.

Today · Series C
₹25 Cr
~6× ₹4 Cr services
Range ₹20–28 Cr · 5–7× floor
Year 1 midpoint
₹42 Cr
6× ₹6.96 Cr topline
Range ₹35–49 Cr · 5–7×
Year 2 midpoint
₹194 Cr
6.5× ₹29.77 Cr topline
Range ₹149–238 Cr · 5–8×
Year 3 midpoint
₹810 Cr
7.5× ₹107.94 Cr topline
Range ₹540–1,079 Cr · 5–10×
Implied EV CAGR
~218% · ₹25 Cr → ₹810 Cr over three years
Locked streams · excluded
Hospital contracts and franchise fees are not in these numbers — every rung is conservatively services + products only.
Multiple defensibility
Comparable AI-first health platforms have raised at ~10× revenue while loss-making. Pro Physio is at cash break-even on ₹4 Cr — these multiples are conservative.
The Y3 midpoint of ₹810 Cr is not a stretch case — it is the centre of a 5–10× revenue band applied to a topline that is itself derived from one consistent formula. The upside band reaches ₹1,079 Cr; the downside floor is ₹540 Cr. Locked hospital and franchise streams sit on top of all of this.
Interactive model

Pull every lever
yourself.

Patient flow, discharge funnel, doctor onboarding, hospital onboarding, full 36-month projection — every assumption is a slider. Move it and the charts, tables and totals update live.

* Locked hospital-contract and franchise streams are excluded from this model — consistent with the rest of the page. Adjust any slider to stress-test the financial story.

AI layer

More depth than
any AI-first platform.

Single-vertical AI health startups have raised eight-figure rounds on narrow models like smart-ICU alone — impressive, but narrow. Pro Physio's AI spans seven verticals across the full patient lifecycle. The clinical data flywheel across 200,000+ patients and three IoT devices creates a moat that gets harder to replicate every month.

Platform comparison — Pro Physio vs AI-only health startups
Single vertical (ICU / radiology)Scope7 AI verticals · full lifecycle
B2B only · hospital SaaSModelB2C + B2B + device + edu + franchise
Nascent clinical dataData200,000+ patients · 3 IoT devices training AI
No physical touchpointMoat13 hospital sites + device fleet + APTA
Revenue: ₹13 Cr · Loss: ₹22 CrUnit economics₹4 Cr · Cash break-even
$14.5M raised · losses wideningCapitalAngel round only · zero debt post-conversion
Pro Physio's AI is not a feature. It is the connective layer across clinical delivery, smart devices, patient engagement, education and franchise operations. Every patient interaction — clinic, home, device, app — feeds the same dataset. The platform becomes more accurate with every session, every device shipped, every course taken. This is the flywheel that AI-only startups cannot replicate without the clinical infrastructure.
Manas AI — psychology layer Live
Mental wellness and psychology AI. Addresses the behavioural and psychological dimensions of chronic pain and recovery — expanding the addressable patient beyond MSK into mental health.
Chronic pain CBTRecovery motivationBehavioural overlay
Wand + Guardian + CryoMat — device AI IoT
Continuous movement, balance, gait, HR and SpO2 data from The Wand trains the Guardian fall-prediction model. CryoMat posture data trains the home-rehab AI. Three devices, one compounding dataset.
Balance analyticsGait deviationFall predictionSpO2 · HRPosture coachingRecovery velocity
MSK assessment + Biological Age Live
AI-guided musculoskeletal intake (Razorpay paid assessment) and biological age calculator. Two AI tools that generate leads, collect health data, and prime patients before their first session.
AI triagePaid assessmentHealth profilingLead conversion
APTA Education AI + Tele-rehab Education
AI-assisted clinical course delivery and outcome tracking for therapist education. APTA credential enables tele-rehab exports to USA/UK — $75–150/session vs ₹800–2,000 in India.
Course AIOutcome trackingTele-rehab $75–150/session
Franchise + Hospital ops AI B2B
Quality monitoring, therapist performance analytics, and outcome benchmarking across hospital sites and franchise units. AI-driven standardisation is the quality moat of a scaled franchise network.
Quality monitoringPerformance analyticsOutcome benchmarking
Who's building the AI

Not a vendor model.
A cross-specialty clinical brain trust.

Pro Physio's AI is not a generic LLM with a clinical skin. Every model — Manas, Wand analytics, Guardian fall prediction, CryoMat coaching, MSK assessment — is co-authored, calibrated, and signed off by a named cross-specialty advisory. The best clinicians, on paper. So the platform is strong, robust, and built for the long horizon: ATH — All Time Health.

Physiotherapy
APTA-credentialled physiotherapists author every clinical protocol the AI delivers — recovery pathways, exercise prescription, outcome tracking. The 100+ therapist network is the labelled-data engine.
Orthopaedic surgery
Post-surgical pathways, return-to-sport protocols and Wand rental indications are co-authored with orthopaedic surgeons across the Apollo, NU and Sakra networks.
Biomechanics
Biomechanists calibrate the sensor stack across Wand, Guardian and CryoMat — gait, balance, posture, rep quality. They define what "good movement" looks like to the model.
Neurology
Neurologists author the Guardian fall-prediction model and the stroke-rehab pathway. Sakra's neurology team contributes labelled data on gait deviation and tremor.
Psychiatry
Psychiatrists shape Manas AI's chronic-pain CBT and recovery-motivation flows — the behavioural layer that lifts adherence on long rehab episodes.
Psychology
Clinical psychologists author the patient-companion tone, motivational interviewing structure and the safeguarding rules embedded in Manas.
Occupational therapy
OTs define activities-of-daily-living scoring used in the home-rehab AI and the elderly-care pathway. Their input is what makes Guardian a care product, not a fall alarm.
Cardiology
Cardiologists set the SpO2 and HR thresholds the Wand uses for safe-to-mobilise decisions in post-surgical and elderly patients — and review every flagged event.
Paediatrics
Paediatricians from Rainbow Children's Hospital author the developmental-delay, autism, and cerebral-palsy pathways the AI surfaces inside the school and clinic programmes.
Sports medicine
Sports physicians author the return-to-sport criteria, load-management thresholds and the academy and gym shop-in-shop protocols.
Geriatrics
Geriatricians author the elderly mobility, frailty and fall-risk scoring used by Wand and Guardian — the largest single demand cohort in the model.
Expanding bench
Pulmonology, oncology rehab, endocrinology, pelvic health, ENT and paediatric neurology specialists join the advisory as each pathway goes live. Every new specialty deepens the moat.
ATH · All Time Health
The deepest cross-specialty clinical brain trust ever assembled in Indian rehabilitation.
The investment thesis is not a single product. It is the cohort of specialists authoring every model. That cohort is the moat — and it is what each new investor is asked to expand.
→
B2B network

13 hospital sites.
Expanding to 17.

Seven named partners. 2,500+ specialist referrers in Bengaluru. Six shop-in-shop channels. A referral engine that took a decade to build.

Hospital partners · current and expanding
5
Rainbow Children's Hospital
5 sites · Bengaluru · paediatric physio, OT, speech therapy
↑6
NU Hospitals
3 current → 6 sites · 3 new Bengaluru openings in pipeline
↑2
Sakra World Hospital
1 current → 2 sites · neurology, stroke rehab, spine
✓
Spire Clinics
Active · outpatient clinic network, Bengaluru
✓
Cytecare Hospitals
Active · oncology and critical care rehabilitation
70+
Apollo Healthcare
70+ hospitals nationally · significant national scale potential
✓
Kara4Kids School
Active · school-embedded paediatric, OT, developmental
Specialist referral TAM · Bengaluru
Orthopaedic surgeons800+
Paediatricians600+
Neurologists400+
Cardiologists350+
Sports medicine200+
Geriatricians150+
Total · 5–10 referrals/doctor/month2,500+
= 12,500–25,000 potential new patients/month vs current 60/day (1,800/month). The referral TAM is 7–14× current new patient volume.
Shop-in-shop channels
Apartment complexes
1,000+ large gated communities · physio pop-up + device sales
Premium gyms + fitness
Cult.fit, Gold's, CrossFit · recovery corner + CryoMat
Sports academies
Cricket, football, badminton · return-to-sport protocols
Elderly care homes
Senior living · Wand + Guardian natural placement
Corporate campuses
12M+ IT workforce · desk physio + CryoMat
Schools + colleges
Sports injury + developmental · Kara4Kids model
Smart device ecosystem

Three devices.
One clinical data flywheel.

Hardware sells once. Subscriptions compound forever. Every device shipped trains the next AI model.

Live now
The Wand
Smart rehabilitation cane. Continuously tracks balance, gait, heart rate and SpO2 via embedded display. Medical-grade IoT for post-surgical, stroke and elderly patients.
Buy price₹23,000
Rental / month₹2,300
Minimum rental12 months
Rental guarantee₹27,600 / patient
Breakeven (buy vs rent)10 months
TargetPost-surgical · stroke · elderly
Coming soon
Guardian
Smart walker for higher-dependency patients. Full gait analysis, fall detection, real-time caregiver alerts. Wand clinical data trains the Guardian AI model.
ModelBuy + monthly care sub
TargetElderly · neuro · high-dep
ChannelElderly homes · Apollo
AIFall predict · carer alerts
Data moatTrained on Wand data
Coming soon
CryoMat
Smart yoga mat with movement sensing, posture correction and guided recovery. Active adults, gyms, apartment complexes — the broadest TAM of the three devices.
ModelBuy + app subscription
TargetActive adults · wellness
ChannelGyms · apartments · online
AIPosture + rep coaching
TAMLargest of the three
International education

Three global bodies.
One Indian platform.

APTA + APA + WCPT simultaneously — India's only tri-international physiotherapy accreditation. Never been done before.

🇺🇸
APTA
American Physical Therapy Association
India host of APTA Pelvic Health. 100,000+ member global body. Advanced clinical courses, CPD certification, India chapter events. The highest credibility signal in global physiotherapy — hosted in India by Pro Physio.
India host of APTA Pelvic Health
🇦🇺
APA
Australian Physiotherapy Association
Co-hosted advanced clinical courses. Internationally recognised certification. Opens the Australian clinical training pipeline. Peer-to-peer faculty exchange between two of the world's strongest physiotherapy traditions.
Co-host partner
🌍
WCPT
World Confederation of Physical Therapists
Global umbrella body representing 121 national associations. Co-hosting elevates Pro Physio to the highest tier of international physiotherapy credibility and opens access to global clinical standards and cross-border tele-rehab frameworks.
121 national associations
Never been done before in India — five layers simultaneously
1
Clinical delivery at scale — 13 hospital sites today, 17 in pipeline, plus shop-in-shop across 6 channel categories
2
Smart device ecosystem — Wand live (₹23K buy / ₹2,300/mo rent), Guardian + CryoMat in pipeline — IoT + SaaS revenue on same patient base
3
Tri-international education — APTA + APA + WCPT — no other Indian physiotherapy organisation has all three
4
AI across every vertical — Manas, device analytics, MSK assessment, biological age — clinical data flywheel across 200,000+ patients
5
Franchise model — asset-light national expansion, brand + protocols + APTA training licensed to operators
→
Physiotherapy as the primary focus. Platform depth as the moat. No competitor anywhere in India has all five simultaneously.
Capital structure

Clean cap table.
Zero debt pre-close.

Three active founders. One strategic investor. Single debt obligation converting to equity before Series C close. Incoming investors see a zero-debt balance sheet from day one.

Shareholding · pre and post conversion
4 shareholders
NestaVera Group50.0%
Pramod Ravindra · CEO17.0%
Bhagwathi Nambi Rajan17.0%
Pratima Nagpal · COO16.0%
All three co-founders are active operators with meaningful equity. No passive shareholders. No ESOP pool — can be discussed as part of the Series C term sheet.
Outstanding debt · converting pre-close
₹2.48 Cr → equity
Converting
LenderNestaVera Group
Principal₹2 Cr · 2022
Rate6% p.a. simple interest
RepaidNil
Accrued interest (4 yrs)~₹48 L
Total converting~₹2.48 Cr
Post-conversion balance sheetZero debt
✓
Zero debt balance sheet for incoming investors
₹2.48 Cr NestaVera debt converts to equity at the pre-agreed pre-money valuation before Series C close. Incoming investors see a clean, zero-debt balance sheet. Lender and equity holder are the same party — single internal agreement.
Why this benefits all parties
→New investor: equity in a debt-free company. No subordinated claims, no cash leaving the business to service debt.
→NestaVera: converts at current valuation before Series C premium. Signals continued conviction in the platform.
→Founders: Series C proceeds deploy fully into growth. Clean governance signal to all incoming investors.
Leadership

Eight leaders.
One shared decade.

PR
Pramod Ravindra
Chief Executive Officer
Physiotherapist. 10+ years clinical and operational leadership. Architect of the APTA Academy of Pelvic Health India partnership. Published author — Quantum Healing. Deccan Herald and national press. Series C lead and primary investor interface.
PN
Pratima Nagpal
Chief Operating Officer
Leads all clinical operations across 13 hospital sites and the home-visit programme. Paediatric physiotherapy specialist. Architect of the Rainbow Children's Hospital embedded programme and Pro Physio's paediatric care pathway.
MM
Manas Mehrotra
Chief Mentor · NestaVera Group
Angel investor since 2019. CA (ICAI), LLB, MBA Babson College USA. Former Global Tax Advisor at Ernst & Young. 60+ years combined investment experience across 52+ portfolio companies.
BN
Bhagwathi Nambirajan
Director of Learning
Leads the APTA, APA and WCPT international education programme. Pelvic health and obstetric physiotherapy specialist. Oversees the learning infrastructure for 100+ therapists and the international clinical education pipeline.
MD
Mahesh Devagiri
Hardware, Engineering & Software Lead — The Wand
Senior semiconductor professional with 27+ years of experience in SoC validation, firmware, BSP, and silicon bring-up. Led global programmes from concept to mass production — contributing to platforms including Qualcomm Snapdragon, Amazon Echo (Alexa), and iPod. At The Wand, oversees software, mobile apps, and data systems, ensuring seamless hardware-software integration.
GB
Gautam Burde
Director — Retail & Distribution · The Wand
20 years in retail, operations and management. Senior roles at Titan Company and Capillary Technologies. Led operations at Simbabet where he built a channel network reaching USD $8M in sales within a year. Currently COO at Pro Physio. At The Wand, owns channel strategy across medical retail, direct-to-consumer, and institutional distribution.
SU
Sandeep Umesh
Chief Financial Officer
Chartered Accountant (ICAI) with senior finance leadership experience across NestaVera Group, 315Work Avenue (VP — Accounts & Finance), Laguna Clothing, and SJH & Co. Chartered Accountants. At Pro Physio, leads financial controls, reporting, fundraising support, and Series C diligence readiness.
View LinkedIn profile
SH
CA Shree Harsha
Financial Strategy, Compliance & Startup Advisory
Chartered Accountant (ICAI) and Managing Partner at Sreshta Business Finance Advisory LLP, specialising in GST, financial regulations, and tax strategy. Founder of SwiftGST and partner at MSH & Associates. Leads financial structuring, investor reporting, and fundraising support at The Wand.
Current investor · angel round · 2019
NestaVera Group
Investment firm · 52+ portfolio companies · Bengaluru · PitchBook listed
"The ProPhysio brand has created a strong positioning of trust and credibility and we are very excited to support them."
Unit economics

LTV:CAC of 15:1.
Rising to 33:1 with The Wand.

Healthcare platforms with embedded devices and subscriptions command the most valuable consumer relationships in any sector. Pro Physio is building exactly this.

LTV — clinical only
₹12,800
2 episodes × 8 sessions × ₹800 avg ticket
Conservative baseline. Every patient who returns doubles this figure.
LTV — clinical + app
₹21,300
Clinical ₹12,800 + App ₹1,999/mo avg 5 months = ₹9,995
30% of app patients renew past first cohort. Platform stickiness at work.
LTV — clinical + app + Wand
₹48,900
Clinical ₹12,800 + App ₹8,500 + Wand rental ₹27,600 (12mo min)
Full platform patient. The Wand alone guarantees ₹27,600 minimum — before any renewal.
CAC (est.)
~₹1,200
Hospital referral ₹0 · Digital ₹500–₹800 · Blended estimate ₹1,200
80%+ of patients arrive via doctor referral or word-of-mouth. CAC stays low as the clinical network scales.
LTV:CAC · base
15:1
SaaS benchmark: 3:1 minimum
LTV:CAC · with Wand
33:1
Top-decile healthcare platform economics
Payback period
<2 sessions
CAC recovered in first 1.5 clinical sessions
Wand rental floor
₹27,600
Guaranteed per patient · 12-month minimum · no renewal assumption needed
Market tailwinds

Twelve forces driving
the same direction.

Pro Physio is not betting on a single trend. It is positioned at the intersection of twelve compounding macro forces — all accelerating simultaneously.

👴
Ageing population
140M → 340M
India's 60+ population triples by 2050. Every person in that cohort is a potential Wand, Guardian, or home-visit patient. The largest guaranteed demand driver in the model.
🧒
Children in the spectrum
8M+ and growing
Autism, ADHD, cerebral palsy, developmental delays — diagnosed cases growing 10%/year. Rainbow Children's Hospital and the paediatric programme sit exactly here.
🏃
Fitness revolution
200M health app users
69% of Indians use health apps (highest globally). The fitness-conscious population demands preventive physiotherapy — and is already paying for digital health subscriptions.
🛡
Preventive services demand
Post-COVID mindset shift
Healthcare spending doubled post-2020. Preventive physio — posture, ergonomics, mobility — is the new wellness category. CryoMat and Gudmedic membership are built for this.
📈
Indian growth trajectory
GDP $5T by 2027
Rising middle class + increasing disposable income + healthcare as aspirational spend. The patient who pays ₹800/session today pays ₹1,500 in three years — 10% price growth is conservative.
💰
Elderly spending power
₹50,000+ monthly spend
India's senior population is the fastest-growing affluent consumer segment. Mobility, independence, and quality of life spending is accelerating — and physiotherapy is the gateway to all three.
🚶
Longevity and mobility
Life expectancy: 70 → 75+
As Indians live longer, the demand for mobility maintenance compounds. Every year of additional life expectancy is a year of potential Wand, Guardian, and home-visit revenue.
🤝
AI cannot replace human touch
The irreplaceable moat
Unlike radiology or diagnostics, physiotherapy requires physical human intervention. AI augments the therapist — it does not replace them. This makes Pro Physio's 100+ therapist network permanently valuable.
🔧
Rehab market fragmented
95%+ unorganised
The Indian rehabilitation market is rudimentary and deeply fragmented — thousands of solo practitioners with no brand, no technology, no recurring revenue. Consolidation creates enormous value.
🏥
Physiopreneur unification
Franchise model
Pro Physio's franchise model unifies smaller practices under a credentialled brand with APTA training, technology, and clinical systems — turning fragmentation into a network effect and growing the collective topline.
💳
Physio financing + equipment rental
Untapped ₹500 Cr+ market
No organised player offers equipment financing or rental to physiotherapy clinics in India. Pro Physio's device fleet (Wand, Guardian, CryoMat) creates the infrastructure to offer both — a capital-light revenue stream with zero new clinical overhead.
🌱
Go-to-market: already built
10 years of trust
Most healthtech startups spend their first three years building clinical credibility. Pro Physio already has it — 200,000+ patients, 13 hospital sites, APTA Pelvic Health host, Times Group award. The go-to-market is the moat.
A note on investor fit
Pro Physio is seeking investors with deep interest or direct experience in the rehabilitation, healthcare, or allied health space — not just financial capital. The right investor understands that physiotherapy is a clinical discipline, that human touch cannot be automated, and that the rehabilitation market is at an identical inflection point to diagnostics in 2010. Strategic capital, mentorship, and network access are as valued as the cheque size.
Invitation-only ecosystem

A closed Series C.
Healthcare professionals only.

No open allocation. No broker introductions. No public roadshow. The Series C is restricted to credentialled healthcare professionals — and every confirmed investor commits to bringing three more credentialled peers into the ecosystem.

01
Credential gate
Every investor must hold an active credential or operating role in the healthcare system. Physicians, surgeons, allied health professionals, hospital owners, medical academics. The cheque is necessary — the credential is required.
02
Three-peer pledge
Each confirmed investor commits to introducing three additional credentialled peers into the platform — as investors, referrers, or franchise candidates. The pledge is signed alongside the term sheet and is the price of entry.
03
1 → 3 → 9 → 27 expansion
Three layers of credentialled introductions produce a 27-peer cohort from a single founding investor — mirroring the franchise and referral engine that already drives the clinical business.
04
No open allocation
There is no broker channel, no syndicate listing, no open page on a platform. Allocation is closed and disclosed only to qualified, introduced healthcare professionals.
How one investor becomes a 27-peer cohort
1 FOUNDING INVESTOR 3 peers 9 peers 27 peers
One credentialled investor → three pledged introductions → nine → twenty-seven. The same compounding pattern that built the franchise and the 2,500+ specialist referral network.
Eligible specialties
Physiotherapy Orthopaedic surgery Neurology Cardiology Paediatrics Sports medicine Geriatrics Psychiatry Psychology Occupational therapy Biomechanics Pulmonology Endocrinology Pelvic health ENT Oncology rehab Hospital owners Medical academics
!
This is an investor qualification model — not an MLM
There is no commission, no downline payout, no recruitment income, and no compensation for introductions. The three-peer pledge is a qualification gate that ensures every investor is also a clinical multiplier. All returns flow only from equity in Pro Physio Healthcare on standard Series C terms.
Investment tiers

Four levels
of involvement.

Open only to credentialled healthcare professionals. Each tier reflects depth of cheque and depth of clinical contribution. All confirmed investors sign the three-peer pledge and receive the same pro-rata rights at the next funding round.

01
Explorer
₹5 – ₹10 Lakhs
Equity stake in Pro Physio
Quarterly investor updates
Pro-rata rights at Series D
One Wand device (complimentary)
Investor community access
Select Explorer
02
Believer
₹10 Lakhs – ₹1 Crore
All Explorer benefits
Annual investor meet, Bengaluru
Locked revenue data access (NDA)
Co-branded APTA course seat · 1/yr
Early access to Guardian + CryoMat
Select Believer
Most impactful
03
Builder
₹1 Crore – ₹10 Crores
All Believer benefits
Observer seat · quarterly board
First right on franchise units
Named in APTA India programme
Shop-in-shop pilot option
Direct line to founders
Select Builder
04
Mentor
₹10 Crores +
All Builder benefits
Board seat · to be agreed
Co-designed growth strategy
Clinic or programme naming rights
Full NDA · all locked streams
Full cap table + financial model
Strategic partnership scope
Select Mentor
Value of investment vs return

What a cheque is worth
at every milestone.

The same valuation ladder, mapped to each tier. Net figures apply a conservative 20% × 20% dilution stack across Series A and Series B (~36% combined dilution → 0.64 retention factor). Numbers assume midpoint outcomes; locked streams remain additive.

Entry · Series C
₹25 Cr
Midpoint pre-money
Y3 midpoint EV
₹810 Cr
7.5× ₹107.94 Cr topline
Gross MOIC · Y3
32.4×
₹810 Cr ÷ ₹25 Cr
Net MOIC · Y3
~20.7×
After 0.64 dilution stack
Tier · indicative cheque
Y1 · ₹42 Cr
Y2 · ₹194 Cr
Y3 gross · ₹810 Cr
Y3 net · post-dilution
Net MOIC
Explorer · ₹10 L
₹16.8 L
₹77.6 L
₹3.24 Cr
₹2.07 Cr
20.7×
Believer · ₹50 L
₹84 L
₹3.88 Cr
₹16.20 Cr
₹10.37 Cr
20.7×
Builder · ₹5 Cr
₹8.4 Cr
₹38.8 Cr
₹162 Cr
₹103.7 Cr
20.7×
Mentor · ₹15 Cr
₹25.2 Cr
₹116.4 Cr
₹486 Cr
₹311 Cr
20.7×
Arithmetic: cheque × valuation step-up (₹42 / ₹194 / ₹810 ÷ ₹25 Cr = 1.68× / 7.76× / 32.4×) for gross figures · Y3 net = Y3 gross × 0.64 to reflect 20% Series A then 20% Series B dilution. Net MOIC is constant across tiers — what scales is rupee value.
Note. These figures assume midpoint outcomes and a standard two-round dilution stack. Locked hospital-contract and franchise streams are additive to every rung, not included. Full sensitivity analysis (downside, midpoint, upside × dilution stress tests) is shared post-NDA at Builder and Mentor tiers.
Open access

Free entry.
No gate, no form.

The full Series C briefing — revenue model, valuation ladder, tier structure and per-cheque returns — is openly available on this page. No expression-of-interest form, no credential check and no pledge are required to read it. When you're ready to talk, reach the founding team directly.

Entire investor briefing open to read — nothing locked behind a form
Talk to the founding team directly, on your terms
Full deck + financial model shared on request
Response within 48 hours · NDA available for deeper diligence
Series C · Open briefing

No application to fill in. Read everything above, then start a conversation whenever it suits you — by call, WhatsApp or email. We'll send the full deck and financial model straight across.

Start a conversation on WhatsApp → Call +91 98808 49999 Email invest@prophysio.ai
Open briefing — share with anyone you think should see it. For deeper diligence, an NDA and the full financial model are available on request.